Therapeutic target
Achieve a euthyroid metabolic state (= thyroid levels in the normal range).
Therapy recommendations
- An indication for thyrostatic therapy (thyrostatic agents) is given when the serum TSH level is <0.3 mU/l. In this case, the TSH serum level should be brought into a range of 0.5-2.0 mU/l by therapy.
Treatment indication in persistent latent hyperthyroidism according to ATA guidelines:
- Persons > 65 years
- Younger patients with concomitant cardiovascular disease or osteoporosis (bone loss).
- Patients with hyperthyroid symptoms
- Postmenopausal women (10 years after the last menstrual period) without estrogen therapy.
Note: Latent hyperthyroidism is considered persistent if TSH monitoring reproduces the initial value after three to six months.
